🎉 The ATHENA trial has recruited 878 participants, exceeding our original target! We're delighted. A huge well done to everyone involved in helping us investigate whether taking amitriptyline can stop long-term pain from shingles.

#GPSky #Primarycare
@riddmj.bsky.social
@capcbristol.bsky.social

WE HAVE REACHED THE END OF RECRUITMENT!! 🎯
Our last randomisations have been completed today 👏
Thank you to everyone involved for your amazing hard work and contributions!

#GPSky #Primarycare
@riddmj.bsky.social
@capcbristol.bsky.social

The ATHENA Study only needs 39 more patients to hit the target of 900. Read more at www.bristol.ac.uk/athena-study
@capcbristol.bsky.social
@nihrspcr.bsky.social

Our research team are on a roll and we are thrilled we now have 846 participants! An amazing achievement! 🙌🥳

Thank you to everyone involved for their hard work...keep going!! 🏃

#GPSky #Primarycare @riddmj.bsky.social
@capcbristol.bsky.social

Congratulations to the @athenastudy.bsky.social team, who have successfully reached their recruitment target of 846 patients 2 months ahead of schedule! 🎉

ATHENA is looking at whether taking amitriptyline tablets can stop long-term pain from shingles.

Find out more: athena-study.bristol.ac.uk

Recruitment update: we have 830 participants so far!
🚀🎯🚀

@capcbristol.bsky.social
@riddmj.bsky.social
#shingles #PrimaryCare #GPSky

Hi! We're on Bluesky!

We're a A NIHR Research funded study, to find out if amitriptyline can prevent pain after shingles (post-herpetic neuralgia).

#PrimaryCare #GPSky
@capcbristol.bsky.social
@riddmj.bsky.social

We are pleased to announce that our protocol paper is out ⬇️

Amitriptyline for the prevention of post-herpetic neuralgia: study protocol for the ATHENA study. Skin Health and Disease, 2025; DOI: doi.org/10.1093/skin...

#PrimaryCare #GPSky
@capcbristol.bsky.social
@riddmj.bsky.social